SCHEDULE 13G

Company

KIORA PHARMACEUTICALS INC

Filed

August 1, 2022

Accession Number

0001213900-22-043137

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →